Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131725 · ClinicalTrials.gov registry record
Cardiac Function Non-Invasive Monitoring System Evaluation Trial
A clinical trial, sponsored by Sensydia Corporation.
- Completed
- Registry status
- 275
- Enrollment target
NCT04131725: Completed study, sponsored by Sensydia Corporation.
NCT04131725 is a clinical trial that has completed, run by Sensydia Corporation. The registered enrollment target is 275 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04131725 has completed, sponsored by Sensydia Corporation.
- COMPLETED
- Registry status
- 275 participants
- Enrollment target
Study Summary
Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)
Primary Outcome
Cardiac function metric measurement including Cardiac Output to report in L/m.
Interventions
- DEVICE Cardiac Performance System (NSR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2023-04-30 |
What the finished NCT04131725 record still lists
NCT04131725 is an observational study that tracks outcomes without assigning an intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Performance System (NSR) is the first listed.
NCT04131725 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04131725 about?
NCT04131725 is a clinical study titled "Cardiac Function Non-Invasive Monitoring System Evaluation Trial". Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)
What is the current status of trial NCT04131725?
This trial is currently completed. The enrollment target is 275 participants. The study started on 2020-11-09. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT04131725?
The interventions under investigation include: Cardiac Performance System (NSR) (DEVICE).
Who is sponsoring clinical trial NCT04131725?
This trial is sponsored by Sensydia Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269190 · 275 participants · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI